NUROW
Neurometrix Inc.
Halal Rating :
Last Price
$0.35
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
NeuroMetrix, Inc. is a commercial stage medical device company that develops and commercializes non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Their primary product is DPNCheck, a point-of-care test that provides accurate and cost-effective screening, diagnosis and monitoring of diabetic peripheral neuropathy (DPN).
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $587314.0 | $2.33m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $769148.0 | $2.6m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $1.09m | $4.35m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Neurometrix Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.